| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on September 25, 2007
Accepted on February 6, 2008
The Liggins Institute and National Research Centre for Growth and Development, University of Auckland, Auckland, New Zealand; Departments of Molecular Biology and Surgery, University of Occupational and Environmental Health, Kitakyushu 807-8555, Japan
* To whom correspondence should be addressed. E-mail: p.lobie{at}auckland.ac.nz.
We have previously demonstrated that the p44/42 MAP kinase pathway is one pathway involved in HOXA1 stimulated oncogenesis. However, inhibition of MEK1 does not completely prevent HOXA1 stimulated oncogenic transformation, suggesting the involvement of additional signal transduction pathways. Here, we report that forced expression of HOXA1 in immortalised human mammary epithelial cells significantly increased levels of STAT3, 5A and 5B mRNA by transcriptional upregulation. The protein levels of STAT3 and 5B (but not STAT5A), and protein phosphorylation levels of STAT3 and 5B were significantly increased by forced expression of HOXA1. Forced expression of STAT3 or STAT5B was sufficient to oncogenically transform an immortalised human mammary epithelial cell line. Accordingly, inhibition of STAT3 or STAT5B activity with dominant negative STAT3 or STAT5B abrogated the ability of HOXA1 to stimulate cell proliferation, survival, oncogenic transformation and generation of large disorganized multiacinar structures in 3D culture. These results suggest that HOXA1 partially mediates oncogenic transformation of the immortalised human mammary epithelial cell through modulation of the STAT3 and STAT5B pathways.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |